1.
Biochemical, Hematological and Immunological Indices Among MDR-TB on Second Line Anti TB and MDR-TB-HIV Co-Infected Patients on Second Line Anti TB and ARV Drugs for a Six -Month Treatment. TMJ [Internet]. 2020 Oct. 7 [cited 2025 May 14];31(3):1-14. Available from: https://www.tmj.or.tz/index.php/tmj/article/view/359